Delving into the Latest Updates on Cryocord Sdn. Bhd. with Synapse

Overview

Tags

Other Diseases

Mesenchymal stem cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Mesenchymal stem cell therapy	1

Objectives:
Primary: To demonstrate the safety of allogeneic UC-MSCs administered by injection for complex perianal fistulas in patients with Crohn's disease
Secondary: To determine the efficacy of a single/multiple allogeneic UC-MSCs injection in improving complex perianal fistula complications and (re-epithelialization of the external openings).

Start Date01 Mar 2022

Sponsor / Collaborator

Cryocord Sdn. Bhd.

[+1]

100 Clinical Results associated with Cryocord Sdn. Bhd.

Login to view more data

0 Patents (Medical) associated with Cryocord Sdn. Bhd.

Login to view more data

100 Deals associated with Cryocord Sdn. Bhd.

Login to view more data

100 Translational Medicine associated with Cryocord Sdn. Bhd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data